{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:13:22Z","timestamp":1792102402148,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Sci Med Pathol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12024-020-00336-y","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T10:02:41Z","timestamp":1605175361000},"page":"130-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A fatal case after an intravenous injection of levamisole"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4014-4028","authenticated-orcid":false,"given":"B\u00e9n\u00e9dicte","family":"Leli\u00e8vre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Suply","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Marcorelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Drevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde Roug\u00e9","family":"Maillart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"336_CR1","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (ANSM). R\u00e9f\u00e9rentiel des ATU nominatives. 2017. https:\/\/www.ansm.sante.fr\/Activites\/Autorisations-temporaires-d-utilisation-ATU\/Referentiel-des-ATU-nominatives\/Referentiel-des-ATU-nominatives. Accessed 14 Nov 2019."},{"key":"336_CR2","first-page":"1166","volume":"176","author":"WH Hsu","year":"1980","unstructured":"Hsu WH. Toxicity and drug interactions of levamisole. JAVMA. 1980;176:1166\u20139.","journal-title":"JAVMA"},{"key":"336_CR3","unstructured":"EMA. https:\/\/www.ema.europa.eu\/en\/documents\/mrl-report\/levamisole-summary-report-1-committee-veterinary-medicinal-products_en.pdf. Accessed 14 Nov 2019."},{"key":"336_CR4","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Recent changes in Europe\u2019s cocaine market. Results from an EMCDDA trendspotter study, 2018. https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/10225\/2018-cocaine-trendspotter-rapid-communication.pdf. Accessed 14 Nov 2019."},{"key":"336_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/jat\/33.9.620","volume":"33","author":"LP Raymon","year":"2009","unstructured":"Raymon LP, Isenschmid DS. Letter to the editor: The possible role of levamisole in illicit cocaine preparations. J Anal Toxicol. 2009;33:620\u20132.","journal-title":"J Anal Toxicol"},{"key":"336_CR6","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00204-017-1947-4","volume":"91","author":"TM Brunt","year":"2017","unstructured":"Brunt TM, van den Berg J, Pennings E, Venhuis B. Adverse effects of levamisole in cocaine users: a review and risk assessment. Arch Toxicol. 2017;91:2303\u201313.","journal-title":"Arch Toxicol"},{"key":"336_CR7","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/clinchem\/37.7.1210","volume":"37","author":"A Turcant","year":"1991","unstructured":"Turcant A, Pr\u00e9mel-Cabic A, Cailleux A, Allain P. Toxicological screening of drugs by microbore high-performance liquid chromatography with photodiode-array detection and ultraviolet spectral library searches. Clin Chem. 1991;37:1210\u20135.","journal-title":"Clin Chem"},{"key":"336_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11419-019-00519-5","volume":"38","author":"B Lelievre","year":"2020","unstructured":"Lelievre B, Richeval C, Coulon A, Ivanikow D, Brofferio M, Deguigne M, et al. Case report on two-cathinones abuse: MPHP and N-ethyl-4\u2019methylnorpentedrone, with a fatal outcome. Forensic Toxicol. 2020;38:243\u201354.","journal-title":"Forensic Toxicol"},{"key":"336_CR9","doi-asserted-by":"crossref","unstructured":"Gruson A, groupe \u201caccr\u00e9ditation\u201d SFTA. Aide \u00e0 la validation des m\u00e9thodes en toxicologie et suivi th\u00e9rapeutique pharmacologique. Ann Toxicol Anal. 2005;S1:1\u201320.","DOI":"10.1051\/ata\/2005040"},{"key":"336_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/infdis\/jit410","volume":"209","author":"RJ Maude","year":"2014","unstructured":"Maude RJ, Silamut K, Plewes K, Charuwatthana P, Ho M, Abul Faiz M, et al. Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia. J Infect Dis. 2014;209:120\u20139.","journal-title":"J Infect Dis"},{"key":"336_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF03189626","volume":"7","author":"M Luyckx","year":"1982","unstructured":"Luyckx M, Rousseau F, Cazin M, Brunet C, Cazin JC, Haguenoer JM, et al. Pharmacokinetics of Levamisole in healthy subjects and cancer patients. Eur J Drug Metab Pharmacokinet. 1982;7:247\u201354.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"336_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/bdd.2510070110","volume":"7","author":"E Kouassi","year":"1986","unstructured":"Kouassi E, Caill\u00e9 G, L\u00e9ry L, Larivi\u00e8re L, V\u00e9zina M. Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos. 1986;7:71\u201389.","journal-title":"Biopharm Drug Dispos"},{"key":"336_CR13","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1007\/s00216-013-6829-x","volume":"405","author":"C Hess","year":"2013","unstructured":"Hess C, Ritke N, Broecker S, Maeda B, Musshoff F. Metabolism of levamisole and kinetics of levamisole and aminorex in urine by means of LC-QTOF-HRMS and LC-QqQ-MS. Anal Bioanal Chem. 2013;405:4077\u201388.","journal-title":"Anal Bioanal Chem"},{"key":"336_CR14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/dta.1619","volume":"6","author":"C Hess","year":"2014","unstructured":"Hess C, Ritke N, Sydow K, Mehling LM, Ruehs H, Maeda B, et al. Determination of levamisole, aminorex, and pemoline in plasma by means of liquid chromatography-mass spectrometry and application to a pharmacokinetic study of levamisole. Drug Test Anal. 2014;6:1049\u201354.","journal-title":"Drug Test Anal"},{"key":"336_CR15","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/cc11441","volume":"16","author":"M Schulz","year":"2012","unstructured":"Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012;16:R136.","journal-title":"Crit Care"},{"key":"336_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.forsciint.2015.02.006","volume":"249","author":"E Pawlik","year":"2015","unstructured":"Pawlik E, Mahler H, Hartung B, Pl\u00e4sser G, Daldrup T. Drug-related death: adulterants from cocaine preparations in lung tissue and blood. Forensic Sci Int. 2015;249:294\u2013303.","journal-title":"Forensic Sci Int"},{"key":"336_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.forsciint.2016.01.005","volume":"265","author":"F Indorato","year":"2016","unstructured":"Indorato F, Romano G, Barbera N. Levamisole-adulterated cocaine: two fatal case reports and evaluation of possible cocaine toxicity potentiation. Forensic Sci Int. 2016;265:103\u20136.","journal-title":"Forensic Sci Int"},{"key":"336_CR18","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jpba.2011.03.039","volume":"55","author":"E Bertol","year":"2011","unstructured":"Bertol E, Mari F, Milia MG, Politi L, Furlanetto S, Karch SB. Determination of aminorex in human urine samples by GC\u2013MS after use of levamisole. J Pharm Biomed Anal. 2011;55:1186\u20139.","journal-title":"J Pharm Biomed Anal"},{"key":"336_CR19","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1124\/dmd.112.045021","volume":"40","author":"A Wolford","year":"2012","unstructured":"Wolford A, McDonald TS, Eng H, Hansel S, Chen Y, Bauman J, et al. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos. 2012;40:1067\u201375.","journal-title":"Drug Metab Dispos"},{"key":"336_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0893-133X(98)00034-7","volume":"19","author":"S Spector","year":"1998","unstructured":"Spector S, Munjal I, Schmidt DE. Effects of the immunostimulant, levamisole, on opiate withdrawal and levels of endogenous opiate alkaloids and monoamine eurotransmitters in rat brain. Neuropsychopharmacology. 1998;19:417\u201327.","journal-title":"Neuropsychopharmacology"},{"key":"336_CR21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.neuropharm.2014.01.002","volume":"79","author":"CS Tallarida","year":"2014","unstructured":"Tallarida CS, Egan E, Alejo GD, Raffa R, Tallarida RJ, Rawls SM. Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine\u2019s action in vivo. Neuropharmacology. 2014;79:590\u20135.","journal-title":"Neuropharmacology"},{"key":"336_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuint.2013.11.010","volume":"73","author":"T Hofmaier","year":"2014","unstructured":"Hofmaier T, Luf A, Seddik A, Stockner T, Holy M, Freissmuth M, et al. Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters. Neurochem Int. 2014;73:32\u201341.","journal-title":"Neurochem Int"},{"key":"336_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2165\/00128071-200405020-00004","volume":"5","author":"N Scheinfeld","year":"2004","unstructured":"Scheinfeld N, Rosenberg JD, Weinberg JM. Levamisole in dermatology. Am J Clin Dermatol. 2004;5:97\u2013104.","journal-title":"Am J Clin Dermatol"},{"key":"336_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0192-0561(83)90065-6","volume":"5","author":"WK Amery","year":"1983","unstructured":"Amery WK, Butterworth BS. The dosage regimen of levamisole in cancer: is it related to efficacy and safety? Int J Immunopharmacol. 1983;5:1\u20139.","journal-title":"Int J Immunopharmacol"},{"key":"336_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0192-0561(92)90179-O","volume":"14","author":"WK Amery","year":"1992","unstructured":"Amery WK, Bruynseels JP. Levamisole, the story and the lessons. Int J Immunopharmacol. 1992;14:481\u20136.","journal-title":"Int J Immunopharmacol"},{"key":"336_CR26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1212\/WNL.45.2.374","volume":"45","author":"DW Kimmel","year":"1995","unstructured":"Kimmel DW, Wijdicks EF, Rodriguez M. Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology. 1995;45:374\u20136.","journal-title":"Neurology"},{"key":"336_CR27","doi-asserted-by":"crossref","unstructured":"Luppi G, Zoboli A, Barbieri F, Crisi G, Piccinini L, Silingardi V. Multifocal leukoencephalopathy associated with 5-fluorouracil and levamisole adjuvant therapy for colon cancer. A report of two cases and review of the literature. Ann Oncol. 1996;7:412\u20135.","DOI":"10.1093\/oxfordjournals.annonc.a010610"},{"key":"336_CR28","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1212\/01.wnl.0000237344.06122.79","volume":"67","author":"HM Liu","year":"2006","unstructured":"Liu HM, Hsieh WJ, Yang CC, Wu VC, Wu KD. Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers. Neurology. 2006;67:1065\u20137.","journal-title":"Neurology"},{"key":"336_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1552-6569.2008.00344.x","volume":"19","author":"N Xu","year":"2009","unstructured":"Xu N, Zhou W, Li S, Zhou G, Zhang N, Liang J. Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients. J Neuroimag. 2009;19:326\u201331.","journal-title":"J Neuroimag"},{"key":"336_CR30","first-page":"511","volume":"26","author":"A Gonz\u00e1lez-Duarte","year":"2013","unstructured":"Gonz\u00e1lez-Duarte A, Williams R. Cocaine-induced recurrent leukoencephalopathy Neuroradiol J. 2013;26:511\u20133.","journal-title":"Cocaine-induced recurrent leukoencephalopathy Neuroradiol J"},{"key":"336_CR31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1212\/WNL.46.1.288","volume":"46","author":"C Chastel","year":"1996","unstructured":"Chastel C, Mabin D. Encephalopathies after levamisole therapy. Neurology. 1996;46:288.","journal-title":"Neurology"},{"key":"336_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12016-013-8376-9","volume":"46","author":"W Tseng","year":"2014","unstructured":"Tseng W, Sutter ME, Albertson TE. Stimulants and the lung. Clin Rev Allergy Immunol. 2014;46:82\u2013100.","journal-title":"Clin Rev Allergy Immunol"},{"key":"336_CR33","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.forsciint.2014.03.028","volume":"240","author":"SB Karch","year":"2014","unstructured":"Karch SB, Defraia B, Messerini L, Mari F, Vaiano F, Bertol E. Aminorex associated with possible idiopathic pulmonary hypertension in a cocaine user. Forensic Sci Int. 2014;240:e7-10.","journal-title":"Forensic Sci Int"}],"container-title":["Forensic Science, Medicine and Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-020-00336-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12024-020-00336-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-020-00336-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T03:06:27Z","timestamp":1613703987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12024-020-00336-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1007\/s12024-020-00336-y","relation":{},"ISSN":["1547-769X","1556-2891"],"issn-type":[{"value":"1547-769X","type":"print"},{"value":"1556-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"26 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}